Interview: Learn groundbreaking progress Emmes is achieving in clinical neuroscience, such as the MDD Psilocybin study featured in 2023 JAMA & new treatment options for children with cerebral palsy from a Phase 3 clinical trial.

https://20580327.fs1.hubspotusercontent-na1.net/hubfs/20580327/SME%20videos%202024/80105%20-%20EMMES%20-%20Courtney%20-%201920%20x%201080.mp4
https://20580327.fs1.hubspotusercontent-na1.net/hubfs/20580327/SME%20videos%202024/80105%20-%20EMMES%20-%20Courtney%20-%201920%20x%201080.mp4
Interview
50